VERGARA BARRA, PABLO ANDRES
Preferred name
VERGARA BARRA, PABLO ANDRES
Main Affiliation
ORCID
0000-0002-6998-8753
Scopus Author ID
57209582372
6 results
Now showing 1 - 6 of 6
- Some of the metrics are blocked by yourconsent settings
Item type:Product, 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Representaciones sociales sobre el suicidio en la adolescencia: Un estudio cualitativo con madres y padres de adolescentes de la comuna de Concepción(SciELO Agencia Nacional de Investigacion y Desarrollo (ANID), 2025-04); 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Women report worse metrics of positive body image and fat talk: Findings of an exploratory study in a Chilean sample(Informa UK Limited, 2025-06-13); Marcell Leonario-RodriguezScopus© Citations 1 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Efficacy of Lactobacillus spp. Interventions to Modulate Mood Symptoms: A Scoping Review of Clinical Trials(MDPI AG, 2025-08-21); María José HormazábalProbiotics containing Lactobacillus spp. have demonstrated immunological and gastrointestinal benefits and may aid in recovery from mood disorders. However, evidence of their mood-modulating efficacy remains inconsistent. Aim: To analyze the efficacy of probiotic interventions with Lactobacillus spp. in modulating mood in humans. A scoping review was conducted following the PRISMA guidelines. A systematic search of the PubMed and Scopus databases was performed using nine Boolean combinations of the terms “mental”, “mental diseases”, “mental disorders”, “gastrointestinal microbiome”, “gut microbiome”, “gut microbiota”, and “lactobacillus”. The search was limited to clinical trials published in English and limited to ten years of publication. Eligible studies met the following criteria: (a) probiotic interventions in adults, with or without mood disturbances; (b) the use of Lactobacillus spp., either alone or in combination; (c) mood assessment instruments applied pre- and post-intervention; and (d) reporting of probiotic concentrations. Trials involving populations with other psychiatric or neurological diagnoses or those combining probiotics with additional mood-modulating nutrients were excluded. From 3291 records, 17 clinical trials met the inclusion criteria. Data extracted included the author, year, population, country of origin, probiotic strain(s), dosage, intervention mode and duration, and outcomes related to the microbial composition, biomarkers, and microbial metabolites. Trials were categorized by probiotic type (single vs. multi-species) and participant profile (healthy individuals and those with depressive symptoms or specific physiological conditions). Preliminary evidence from single-strain interventions, particularly high-dose L. plantarum administered for ≥8 weeks, suggests potential improvements in anxiety, sleep quality, and inflammatory biomarkers. Multi-species formulations yielded reductions in depressive symptoms and changes in neurobiological markers. Nonetheless, substantial heterogeneity in strains, dosages, durations, and outcome measures limited cross-study comparisons. Lactobacillus spp. interventions show promising mood-modulating potential, especially with specific strains and prolonged administration. Standardized protocols, rigorous controls, and clearly defined clinical cohorts are needed to establish robust, evidence-based recommendations.5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Sociocultural influence on body, physical activity and anxiety are related to the symptomatology of muscle dysmorphia in young adults in Temuco: An exploratory analysis(2024)5